Skip to content

Diagnosis of periodontal disease using genetic marker in saliva

Identification of novel periodontal disease biomarkers using miRNA expression in saliva

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0001024
Enrollment
18
Registered
2014-03-18
Start date
2015-03-20
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : non-surgical periodontal therapy

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: A. Advanced Periodontal Disease - Patients with chronic advaced periodontitis - Patients required primary treatment of periodontal scaling, subgingival curettage, and agreed with the basic periodontal therapy based on the standard protocol - subjects agreed collecting saliva and gingival crevicular fluid and physicochemical tests and genetic testing B. Mild Periodontal Disease - Patients with chronic initial periodontitis - Patients required primary treatment of periodontal scaling, subgingival curettage, and agreed with the basic periodontal therapy based on the standard protocol - subjects agreed collecting saliva and gingival crevicular fluid and physicochemical tests and genetic testing C. Control - Healthy periodontal patients ( more than 20 permanent teeth are present , in all parts of deep periodontal pockets measuring 4mm or less, and height is 2mm or less clinical attachment person) - subjects agreed collecting saliva and gingival crevicular fluid and physicochemical tests and genetic testing

Exclusion criteria

Exclusion criteria: - Received periodontal treatment within the last six months - recently taken antibiotics within 3 months if you need a prescription antibiotic prophylaxis - taking the drug can affect periodontal status for a long period of time - pregnant or breastfeeding - In case of oral inflammatory mucosal disease (Lichen planus, etc.) - Patients with a history of alcoholism or drug abuse - other special systemic disease (high blood pressure) - ages under 18

Design outcomes

Primary

MeasureTime frame
espression of MicroRNA

Secondary

MeasureTime frame
cytokine analysis

Countries

Korea, Republic of

Contacts

Public ContactSu-Hwan Kim

Asan Medical Center

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026